ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma.
Wu C, Yang T, Liu Y, Lu Y, Yang Y, Liu X, Liu X, Ye L, Sun Y, Wang X, Li Q, Yang P, Yu X, Gao S, Kumar S, Jin F, Dai Y, Li W.
Wu C, et al. Among authors: dai y.
Cancer Med. 2018 Aug;7(8):3899-3911. doi: 10.1002/cam4.1596. Epub 2018 Jun 21.
Cancer Med. 2018.
PMID: 29926531
Free PMC article.